Open Beta
TREN
MetriLume
TREN

US marketsIRWD

SEC-sourced researchBeta

IRWD

IRONWOOD PHARMACEUTICALS INC

Company comparison ↗

Data passport

CIK
0001446847
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
5/6
Filing date
Sep 23, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 351,410,000.0000 USD; December 2025: 296,151,000.0000 USD351.4M USD0 USD0December 2024December 2025
IRWD · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2024351,410,000.0000Feb 26, 2026
December 2025296,151,000.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025296,151,000.000024,017,000.0000127,044,000.0000396,901,000.0000—Feb 26, 2026
December 2024351,410,000.0000880,000.0000103,549,000.0000350,908,000.0000—Feb 26, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$296.15MDecember 2025Feb 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$351.41MDecember 2024Feb 26, 202610-K
Net incomeNetIncomeLoss$24.02MDecember 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$127.04MDecember 2025Feb 26, 202610-K
Total assetsAssets$396.9MDecember 2025Feb 26, 202610-K
Total liabilities————

New filings

Explore methodology ↗